Prediction of Symptom Change in Placebo Versus No-Treatment Group in Experimentally Induced Motion Sickness

Applied Psychophysiology Biofeedback

Volumn 40, Issue 3, 2015, Pages 163-172

  Horing, Bjoern ^a,b   Weimer, Katja ^a   Muth, Eric R ^b   Enck, Paul ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

Locus of control; Motion sickness; Placebo response; Placebo response prediction; Self efficacy

Indexed keywords

PLACEBO;

ADULT; ANXIETY; CONTROL; FEMALE; HUMAN; MALE; MOTION SICKNESS; OUTCOME ASSESSMENT; PHYSIOLOGY; PLACEBO EFFECT; PROGNOSIS; PSYCHOLOGY; SELF CONCEPT; TEMPERAMENT; YOUNG ADULT;

ADULT; ANXIETY; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; MALE; MOTION SICKNESS; OUTCOME ASSESSMENT (HEALTH CARE); PLACEBO EFFECT; PLACEBOS; PROGNOSIS; SELF EFFICACY; TEMPERAMENT; YOUNG ADULT;

EID: 84938954280     PISSN: 10900586     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10484-015-9284-y     Document Type: Article

References (62)

1. Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review,84(2), 191–215.
2. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
3. Benedetti, F. (2009). Placebo effects: Understanding the mechanisms in health and disease. New York: Oxford University Press.
4. Bingel, U. (2014). Avoiding nocebo effects to optimize treatment outcome. JAMA,312(7), 693–694. doi:10.1001/jama.2014.8342.
5. Bootzin, R. R., & Caspi, O. (2002). Explanatory mechanisms for placebo effects: cognition, personality and social learning. In H. A. Guess (Ed.), The science of the placebo: Toward an interdisciplinary research agenda (1st ed., pp. 108–132). London: BMJ Books.
6. Breckenridge, R. L., & Dodd, M. O. (1991). Locus of control and alcohol placebo effects on performance in a driving simulator. Perceptual and Motor Skills,72(3 Pt 1), 751–756.
7. Brockner, J. (1988). Self-esteem at work: Research, theory and practice. Lexington: D.C. Heath & Co.
8. Colloca, L., & Miller, F. G. (2011). Harnessing the placebo effect: the need for translational research. Philosophical Transactions of the Royal Society B: Biological Sciences,366(1572), 1922–1930. doi:10.1098/rstb.2010.0399.
9. Cousins, M., & Power, I. (1999). Acute and postoperative pain. In P. D. Wall & R. Melzack (Eds.), Textbook of pain (4th ed., pp. 447–491). Edinburgh: Churchill Livingstone.
10. Dolce, J. J., Doleys, D. M., Raczynski, J. M., Lossie, J., Poole, L., & Smith, M. (1986). The role of self-efficacy expectancies in the prediction of pain tolerance. Pain,27(2), 261–272. doi:10.1016/0304-3959(86)90216-2.
11. Eden, D., & Zuk, Y. (1995). Seasickness as a self-fulfilling prophecy: Raising self-efficacy to boost performance at sea. Journal of Applied Psychology,80(5), 628–635.
12. Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013). The placebo response in medicine: Minimize, maximize or personalize? Nature Reviews Drug Discovery,12(3), 191–204. doi:10.1038/nrd3923.
13. Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010). Biological, clinical, and ethical advances of placebo effects. Lancet,375(9715), 686–695. doi:10.1016/S0140-6736(09)61706-2.
14. Flaten, M. A., Aslaksen, P. M., Lyby, P. S., & Bjorkedal, E. (2011). The relation of emotions to placebo responses. Philosophical Transactions of the Royal Society B: Biological Sciences,366(1572), 1818–1827. doi:10.1098/rstb.2010.0407.
15. Fricchione, G., & Stefano, G. B. (2005). Placebo neural systems: Nitric oxide, morphine and the dopamine brain reward and motivation circuitries. Medical Science Monitor,11(5), MS54–MS65.
16. Geers, A. L., Helfer, S. G., Kosbab, K., Weiland, P. E., & Landry, S. J. (2005). Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response. Journal of Psychosomatic Research,58(2), 121–127. doi:10.1016/j.jpsychores.2004.08.011.
17. Geers, A. L., Wellman, J. A., Fowler, S. L., Helfer, S. G., & France, C. R. (2010). Dispositional optimism predicts placebo analgesia. Journal of Pain,11(11), 1165–1171. doi:10.1016/j.jpain.2010.02.014.
18. Glaesmer, H., Hoyer, J., Klotsche, J., & Herzberg, P. Y. (2008). Die deutsche Version des Life-Orientation-Tests (LOT-R) zum dispositionellen Optimismus und Pessimusmus. Zeitschrift fur Gesundheitspsychologie,16(1), 26–31.
19. Glaesmer, H., Rief, W., Martin, A., Mewes, R., Brahler, E., Zenger, M., & Hinz, A. (2012). Psychometric properties and population-based norms of the Life Orientation Test Revised (LOT-R). British Journal of Health Psychology,17(2), 432–445.
20. Hall, K. T., Lembo, A. J., Kirsch, I., Ziogas, D. C., Douaiher, J., Jensen, K. B., et al. (2012). Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS ONE,7(10), e48135. doi:10.1371/journal.pone.0048135PONE-D-12-18110.
21. Hautzinger, M., Keller, F., & Kühner, C. (2009). BDI-II. Beck-Depressions-Inventory. Revision (2nd ed.). Frankfurt: Pearson Assessment.
22. Heatherton, T. F., Polivy, J., & Herman, C. P. (1989). Restraint and internal responsiveness: Effects of placebo manipulations of hunger state on eating. Journal of Abnormal Psychology,98(1), 89–92.
23. Hoffman, G. A., Harrington, A., & Fields, H. L. (2005). Pain and the placebo: What we have learned. Perspectives in Biology and Medicine,48(2), 248–265. doi:10.1353/pbm.2005.0054.
24. Horing, B., Weimer, K., Muth, E. R., & Enck, P. (2014). Prediction of placebo responses: a systematic review of the literature. Frontiers in Psychology,5, 1079. doi:10.3389/fpsyg.2014.01079.
25. Horing, B., Weimer, K., Schrade, D., Muth, E. R., Scisco, J. L., Enck, P., & Klosterhalfen, S. (2013). Reduction of motion sickness with an enhanced placebo instruction: An experimental study with healthy participants. Psychosomatic Medicine,75(5), 497–504. doi:10.1097/PSY.0b013e3182915ee7.
26. Hrobjartsson, A., & Boutron, I. (2011). Blinding in randomized clinical trials: Imposed impartiality. Clinical Pharmacology and Therapeutics,90(5), 732–736. doi:10.1038/clpt.2011.207.
27. Hrobjartsson, A., Kaptchuk, T. J., & Miller, F. G. (2011). Placebo effect studies are susceptible to response bias and to other types of biases. Journal of Clinical Epidemiology,64(11), 1223–1229. doi:10.1016/j.jclinepi.2011.01.008.
28. Jose, P. E. (2013). Doing statistical mediation and moderation. New York: Guilford Press.
29. Kaptchuk, T. J., Kelley, J. M., Deykin, A., Wayne, P. M., Lasagna, L. C., Epstein, I. O., et al. (2008). Do “placebo responders” exist? Contemporary Clinical Trials,29(4), 587–595. doi:10.1016/j.cct.2008.02.002.
30. Kienle, G. S., & Kiene, H. (1997). The powerful placebo effect: fact or fiction? Journal of Clinical Epidemiology,50(12), 1311–1318.
31. Krampen, G. (1991). Fragebogen zu Kompetenz- und Kontrollüberzeugungen (FKK). Göttingen: Hogrefe.
32. Krogsboll, L. T., Hrobjartsson, A., & Gotzsche, P. C. (2009). Spontaneous improvement in randomised clinical trials: Meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Medical Research Methodology,9, 1. doi:10.1186/1471-2288-9-1.
33. Krummenacher, P., Candia, V., Folkers, G., Schedlowski, M., & Schonbachler, G. (2010). Prefrontal cortex modulates placebo analgesia. Pain,148(3), 368–374. doi:10.1016/j.pain.2009.09.033.
34. Laux, L., Glanzmann, P., Schaffner, P., & Spielberger, C. D. (1981). Das State-Trait-Angstinventar. Weinheim: Beltz.
35. Leuchter, A. F., McCracken, J. T., Hunter, A. M., Cook, I. A., & Alpert, J. E. (2009). Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. Journal of Clinical Psychopharmacology,29(4), 372–377. doi:10.1097/JCP.0b013e3181ac4aaf.
36. Levenson, H. (1972). Distinctions within the concept of internal–external control: Development of a new scale. Proceedings of the Annual Convention of the American Psychological Association,7(1), 261–262.
37. Levine, J. D., Gordon, N. C., Bornstein, J. C., & Fields, H. L. (1979). Role of pain in placebo analgesia. Proceedings of the National Academy of Sciences,76(7), 3528–3531.
38. Levine, M. E., Stern, R. M., & Koch, K. L. (2014). Enhanced perceptions of control and predictability reduce motion-induced nausea and gastric dysrhythmia. Experimental Brain Research,. doi:10.1007/s00221-014-3950-9.
39. Lyby, P. S., Aslaksen, P. M., & Flaten, M. A. (2010). Is fear of pain related to placebo analgesia? Journal of Psychosomatic Research,68(4), 369–377. doi:10.1016/j.jpsychores.2009.10.009.
40. Lyby, P. S., Forsberg, J. T., Asli, O., & Flaten, M. A. (2012). Induced fear reduces the effectiveness of a placebo intervention on pain. Pain,153(5), 1114–1121. doi:10.1016/j.pain.2012.02.042.
41. Miller, B. L., & Cummings, J. L. (Eds.). (2007). The human frontal lobes: Functions and disorders (2nd ed.). New York: The Guilford Press.
42. Morton, D. L., Watson, A., El-Deredy, W., & Jones, A. K. (2009). Reproducibility of placebo analgesia: Effect of dispositional optimism. Pain,146(1–2), 194–198. doi:10.1016/j.pain.2009.07.026.
43. Muth, E. R. (2006). Motion and space sickness: Intestinal and autonomic correlates. Autonomic Neuroscience,129(1–2), 58–66. doi:10.1016/j.autneu.2006.07.020.
44. Ober, K., Benson, S., Vogelsang, M., Bylica, A., Gunther, D., Witzke, O., et al. (2011). Plasma noradrenaline and state anxiety levels predict placebo response in learned immunosuppression. Clinical Pharmacology and Therapeutics,91(2), 220–226. doi:10.1038/clpt.2011.214.
45. Petrovic, P., Dietrich, T., Fransson, P., Andersson, J., Carlsson, K., & Ingvar, M. (2005). Placebo in emotional processing–induced expectations of anxiety relief activate a generalized modulatory network. Neuron,46(6), 957–969. doi:10.1016/j.neuron.2005.05.023.
46. Quinn, V. F., & Colagiuri, B. (2014). Placebo interventions for nausea: A systematic review. Annals of Behavioral Medicine. doi:10.1007/s12160-014-9670-3.
47. Reason, J. T., & Brand, J. J. (1975). Motion sickness. London: Academic Press.
48. Ruch, W., Angleitner, A., & Strelau, J. (1991). The Strelau Temperament Inventory-Revised (STI-R): Validity studies. European Journal of Personality,5, 287–308.
49. Scheier, M. F., Carver, C. S., & Bridges, M. W. (1994). Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. Journal of Personality and Social Psychology,67(6), 1063–1078.
50. Schroeder, M. A. (1990). Diagnosing and dealing with multicollinearity. Western Journal of Nursing Research,12(2), 175–184.
51. Schwarzer, R., Greenglass, E. & Taubert, S. (2000). PCI – Fragebogen zu allgemeiner und proaktiver Stressbewältigung: Deutsche Testversion 1 (2000) des Proactive Coping Inventory. Retrieved 2015/01/07, from http://userpage.fu-berlin.de/~health/pcigerman1.htm
52. Schwarzer, R. & Jerusalem, M. (1999). Skalen zur Erfassung von Lehrer- und Schülermerkmalen. Dokumentation der psychometrischen Verfahren im Rahmen der wissenschaftlichen Begleitung des Modellversuchs Selbstwirksame Schulen [Scales to assess teacher and student characteristics. Documentation of psychometric methods in the context of scientific monitoring of the model experiment “Self-efficacious schools”]. Berlin: Freie Universität Berlin.
53. Schweinhardt, P., Seminowicz, D. A., Jaeger, E., Duncan, G. H., & Bushnell, M. C. (2009). The anatomy of the mesolimbic reward system: A link between personality and the placebo analgesic response. Journal of Neuroscience,29(15), 4882–4887. doi:10.1523/JNEUROSCI.5634-08.2009.
54. Shapiro, A. K., & Shapiro, E. (1997). The powerful placebo: From ancient priest to modern physician. Baltimore: Johns Hopkins University Press.
55. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1970). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
56. Stockhorst, U., Steingrueber, H. J., Enck, P., & Klosterhalfen, S. (2006). Pavlovian conditioning of nausea and vomiting. Autonomic Neuroscience,129(1–2), 50–57. doi:10.1016/j.autneu.2006.07.012.
57. Strelau, J., & Angleitner, A. (1994). Cross-cultural studies on temperament: Theoretical considerations and empirical studies based on the Pavlovian Temperament Survey. Personality and Individual Differences,16(2), 331–342.
58. Strelau, J., Angleitner, A., Bantelmann, J., & Ruch, W. (1990). The Strelau Temperament Inventory-Revised (STI-R): Theoretical considerations and scale development. European Journal of Personality,4, 209–235.
59. Weimer, K., Colloca, L. & Enck, P. (2014). Age and sex as moderators of the placebo response—An evaluation of systematic reviews and meta-analyses across medicine. Gerontology,61(2), 97–108.
60. Weimer, K., & Enck, P. (2014). Traditional and innovative experimental and clinical trial designs and their advantages and pitfalls. Handbook of Experimental Pharmacology,225, 237–272. doi:10.1007/978-3-662-44519-8_14.
61. Weimer, K., Horing, B., Muth, E. R., & Enck, P. (2014b). How to study placebo responses in motion sickness with a rotation chair paradigm in healthy participants. Journal of Visualized Experiments. doi:10.3791/52471.
62. Williamson, M. J., Thomas, M. J., & Stern, R. M. (2004). The contribution of expectations to motion sickness symptoms and gastric activity. Journal of Psychosomatic Research,56(6), 721–726. doi:10.1016/S0022-3999(03)00130-2.